Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Small Cell Lung Carcinoma × Cisplatin × Clear all

Phase

Status

Sponsor Class

OTHER 46 INDUSTRY 30 NIH 5 NETWORK 2 UNKNOWN 1 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 3 Stomach Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Nasopharyngeal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

apatinib 2 Etoposide 2 tislelizumab 1 camrelizumab 1 anlotinib 1 Radiotherapy 1 Irinotecan 1 Immunotherapy 1 Drug Therapy 1 Cisplatin 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02323737 2014-12-30

Phase II Study of Irinotecan and Cisplatin in Extensive-stage Small Cell Lung Cancer

ChineseAMS

Phase 2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡